FindTrial
Sign In

A prospective, randomised, placebo-controlled, blinded trial of gabapentin in chronic groin pain following groin hernia repair

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN43433116
Enrollment
Unknown
Registered
2003-09-12
Start date
2004-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Signs and Symptoms: Pain Signs and Symptoms Pain

Interventions

Patients will be randomised into two groups who present with chronic inguinodynia - gabapentin or placebo. A preliminary questionnaire will be administered and pain scores will be recorded. Patients

Sponsors

Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Not provided at time of registration

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
That gabapentin, an anticonvulsant drug used in the treatment of neuropathic pain, significantly reduces pain in patients with inguinodynia.—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026